Speakers
Christoph Guetter, PhD, Director of Algorithm Development at Roche

Saleh Miri, PhD, Sub-Chapter Lead, DP Algorithm Pharma Services at Roche

Learning Objectives

• Understand the utility of artificial intelligence (AI) and machine learning (ML) in the development of image analysis tools for digital pathology, and understand current AI/ML methods and how they address the different aspects of AI development.
• Acquire foundational levels of knowledge in the areas of DP infrastructure as well as underlying AI, machine learning and neural network approaches.
• Awareness of the importance of generating high-quality Ground-Truth (GT) for training, tuning, and testing of AI/ML methods
• Insights into the value of standardization during algorithm development and the variables that can impact the performance of AI tools.
• Understanding of the pathologist's role in image analysis algorithm development.
• Interpret the importance of AI & Ethics and how its inclusion is foundational to the development and deployment of these tools.  

Interested in learning more? Fill out the form to be contacted by a Roche representative

Roche Digital Pathology Dx, including navify Digital Pathology, is intended for specific clinical applications and is for research and educational use for other applications. Please review the product labeling for compliance before utilization.

*Roche Image Analysis Algorithms and Roche Open Environment Algorithms are for research use only. Not for use in diagnostic procedures.